2 members of Congress have disclosed 4 trades in Oramed Pharmaceuticals Inc. (ORMP) since 2021: 1 purchase worth about $8.00K and 3 sales worth about $48.50K. The most active was Brad Knott, with 1 trade. The latest trade was made on Jan 10, 2025.
ORMP’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought ORMP, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Brad KnottR-NC | 1 | 0 | 1 | $0.00 | $32.50K | -$32.50K | – | Jan 10, 2025 | Jan 10, 2025 |
| 2 | Andrew R. GarbarinoR-NY | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | -139.6% | Apr 23, 2021 | Jan 14, 2022 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Brad KnottR-NC | ORMPOramed Pharmaceuticals Inc. - Common Stock | Self | Sell | $15K–$50K | Jan 10, 2025 | Feb 25, 2025 | 46d late | +67.4% | +37.8% | |
| Andrew R. GarbarinoR-NY | ORMPOramed Pharmaceuticals Inc. | Self | Sell | $1K–$15K | Jan 14, 2022 | Jan 14, 2022 | 0d | -63.8% | -125.7% | |
| Andrew R. GarbarinoR-NY | ORMPOramed Pharmaceuticals Inc. | Self | Sell (Partial) | $1K–$15K | Oct 1, 2021 | Nov 3, 2021 | 33d | -80.9% | -154.1% | |
| Andrew R. GarbarinoR-NY | ORMPOramed Pharmaceuticals Inc. | Self | Buy | $1K–$15K | Apr 23, 2021 | May 24, 2021 | 31d | -59.1% | -139.6% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
2 members of Congress have disclosed 4 trades in Oramed Pharmaceuticals Inc. (ORMP) since 2021: 1 purchase worth about $8.00K and 3 sales worth about $48.50K. The most active was Brad Knott, with 1 trade. The latest trade was made on Jan 10, 2025. Most active: Brad Knott (1), Andrew R. Garbarino (3).
Since 2021 they have disclosed 1 purchase and 3 sales; by the midpoints of the disclosed ranges, about $8.00K bought and $48.50K sold, a net sale of $40.50K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded ORMP on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.